Literature DB >> 20545585

Recent developments in pharmacoeconomic evaluation in Ireland.

Lesley Tilson, Michael Barry.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20545585     DOI： 10.1586/erp.10.33

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  9 in total

1.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

2.  Optimizing pharmacotherapy in older patients: a European perspective.

Authors:  Denis O'Mahony; Antonio Cherubini; Mirko Petrovic
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  Use of economic evaluation in decision making: evidence and recommendations for improvement.

Authors:  Steven Simoens
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

4.  The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?

Authors:  James F O'Mahony; Diarmuid Coughlan
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

5.  How to assess the value of medicines?

Authors:  Steven Simoens
Journal:  Front Pharmacol       Date:  2010-09-07       Impact factor: 5.810

6.  Valorising and creating access to innovative medicines in the European union.

Authors:  Lieven Annemans; Irina Cleemput; Frank Hulstaert; Steven Simoens
Journal:  Front Pharmacol       Date:  2011-10-11       Impact factor: 5.810

Review 7.  A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Authors:  Lianne Barnieh; Fiona Clement; Anthony Harris; Marja Blom; Cam Donaldson; Scott Klarenbach; Don Husereau; Diane Lorenzetti; Braden Manns
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

8.  Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.

Authors:  Sarah-Jo Sinnott; Kathleen Bennett; Caitriona Cahir
Journal:  Eur J Clin Pharmacol       Date:  2017-08-17       Impact factor: 2.953

Review 9.  The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review.

Authors:  Y Schuller; C E M Hollak; M Biegstraaten
Journal:  Orphanet J Rare Dis       Date:  2015-07-30       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.